Shah, Jatin J.
Emory University · National and Kapodistrian University of Athens · NYU Langone Health · Karyopharm Therapeutics (United States) · Abramson Cancer Center · Tisch Cancer Institute · University of Pennsylvania · Icahn School of Medicine at Mount Sinai
7 papers on CoChat
Most cited papers
- Verified
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study
Kumar, S. K., Lee, J. H., Lahuerta, J. J., Morgan, G., Richardson, P. G., Crowley, J., Haessler, J., Feather, J., Hoering, A., Moreau, P., et al. (2012) · Leukemia
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 721
- Verified
Oral selinexor-dexamethasone for triple-class refractory multiple myeloma.
Chari, A., Vogl, D. T., Gavriatopoulou, M., Nooka, A. K., Yee, A. J., Huff, C. A., Moreau, P., Dingli, D., Cole, C., Lonial, S., et al. (2019) · New England Journal of Medicine
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 666
- Verified
Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications
Bjorklund, C. C., Baladandayuthapani, V, Lin, H. Y., Jones, R. J., Kuiatse, I., Wang, H., Yang, J., Shah, J. J., Thomas, S. K., Wang, M., et al. (2014) · Leukemia
Multiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors
Cited by 131
- Verified
Evidence of a Role for Activation of Wnt/β-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide
Bjorklund, C. C., Ma, W., Wang, Z.-Q., Davis, R. E., Kuhn, D. J., Kornblau, S. M., Wang, M., Shah, J. J., & Orlowski, R. Z. (2011) · Journal of Biological Chemistry
Multiple Myeloma Research and TreatmentsWnt/β-catenin signaling in development and cancer
Cited by 130
- Verified
Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma
Liu, H., Liu, Z., Du, J., He, J., Lin, P., Amini, B., Starbuck, M. W., Novane, N., Shah, J. J., Davis, R. E., et al. (2016) · Science Translational Medicine
Bone Metabolism and DiseasesMultiple Myeloma Research and Treatments
Cited by 74
- Verified
Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial
Shah, J. J., Feng, L., Thomas, S. K., Berkova, Z., Weber, D. M., Wang, M., Qazilbash, M. H., Champlin, R. E., Mendoza, T. R., Cleeland, C., et al. (2016) · Blood Cancer Journal
Multiple Myeloma Research and TreatmentsBone health and treatments
Cited by 35
- Verified
Outcome of patients with immunoglobulin light-chain amyloidosis with lung, liver, gastrointestinal, neurologic, and soft tissue involvement after autologous hematopoietic stem cell transplantation
Afrough, A., Saliba, R. M., Hamdi, A., El Fakih, R., Varma, A., Dinh, Y. T., Rondon, G., Cornelison, A. M., Shah, N. D., Bashir, Q., et al. (2015) · Biology of Blood and Marrow Transplantation
Amyloidosis: Diagnosis, Treatment, OutcomesMultiple Myeloma Research and Treatments
Cited by 6
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free